Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - GB
$ 10.625
4.37 %
$ 48.5 B
Market Cap
26.56
P/E
Price Target
Average
--8.94%
Revenue Forecast
Estimate
12.95%
EBIT
Estimate
10.59%
Net Income
Estimate
61.11%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Haleon plc
Wall Street analysts predict an average 1-year price target for HLN of $9.68 , with forecasts ranging from
a
low of
$9.15 to a high of $10.2 .
HLN Lowest Price Target
Wall Street Target
9.15 USD
-13.88%
HLN Average Price Target
Wall Street Target
9.68 USD
-8.94%
HLN Highest Price Target
Wall Street Target
10.2 USD
-4.00%
REVENUE FORECAST
Revenue Forecast Chart HLN
EBIT FORECAST
EBIT Forecast Chart HLN
NET INCOME FORECAST
Net Income Chart HLN